BGI has opened a genomics research center in Copenhagen's Bio Science Park that will be equipped with 10 Illumina HiSeq 2000 sequencers.

The goal of the center is to establish collaborations in genomics research and its applications to health care, agriculture, and bioenergy.

The center will kick off with two main initiatives: a cancer vaccine project and the 1% Danes' Genome Project.

The cancer vaccine project aims to use sequencing to identify unknown cancer pathogens and develop and patent commercial vaccines.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.